제놀루션

225220KOSDAQ기초 의약물질 제조업

62.8 / 100

Reference Date: 2026-07-24

Financial Score23.5 / 40

News Sentiment21.3 / 25

Momentum8.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but Operating Profit is on a declining trend. Surged 26.7% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Genolux operates in the molecular diagnostic equipment and RNAi research sectors, offering automated nucleic acid extraction devices and RNA synthesis services. The company has developed the world's first RNAi-based treatment for foulbrood disease in bees and obtained product approval, while expanding its RNAi-based agricultural pest control technologies.

Number of Employees

76people

Average Salary

53.4M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 25.444.0Point

PBR

0.37Industry Average 1.267.0Point

Half of industry avg (excellent)

ROE

-16.98Industry Average -6.033.5Point

2.8x industry avg (excellent)

Debt Ratio

0.44Industry Average 6.628.0Point

Half of industry avg (excellent)

Trend 2023~20251.0 / 10 points

Revenue Growth Rate

1.0 / 3

Avg ▲2.4% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼11.8% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -10.6% (declining, 3yr)

Detailed News Sentiment

5 totalPositive 5Neutral 0Negative 0Average Sentiment Score 85

Positive
김민이 제놀루션 공동대표, 2400만원 규모 자사주 매수
제놀루션 공동대표 김민이의 대규모 자사주 매수로 기업 신뢰도 상승 기대.
Positive
제놀루션, 고추 바이러스 표적 RNA 농약 특허 출원…글로벌 시장 공략
제놀루션의 BBWV2 표적 RNA 농약 특허 출원으로 고추 바이러스 피해 해결에 대한 혁신적 접근이 기대되며, 글로벌 시장 진출 가능성이 높아짐.
Positive
제놀루션, RNA 농약 파이프라인 확대…고추 바이러스 방제 기술 확보
제놀루션의 새로운 RNA 간섭 기술이 BBWV2 바이러스 방제에 성공적으로 적용되어 고추 재배에 긍정적 영향을 미칠 것으로 예상됩니다.

Detailed Momentum

52-week position1.0Point

Near 52w low (17%, downtrend)

Current 1,305Won52-week high 2,59052-week low 1,030

1-month return6.0Point

1m +26.70% (strong rise)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

5 totalPositive 0Neutral 5Negative 0

Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-07-22
Neutral임원ㆍ주요주주특정증권등거래계획보고서2026-07-01
Neutral주식등의대량보유상황보고서(일반)2026-07-01
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-06-30
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-06-30